rdf:type |
|
lifeskim:mentions |
umls-concept:C0003241,
umls-concept:C0008356,
umls-concept:C0020971,
umls-concept:C0026584,
umls-concept:C0026809,
umls-concept:C0028778,
umls-concept:C0030498,
umls-concept:C0032154,
umls-concept:C0205263,
umls-concept:C0229671,
umls-concept:C0442118,
umls-concept:C1521797
|
pubmed:issue |
23
|
pubmed:dateCreated |
2003-6-13
|
pubmed:abstractText |
Transmission-blocking vaccines (TBVs) targeting ookinete surface proteins expressed on sexual-stage malaria parasites are considered one promising strategy for malaria control. To evaluate the prospect of developing non-invasive and easy-to-administer mucosal malaria transmission-blocking vaccines, mice were immunized intranasally with a Plasmodium vivax ookinete surface protein, Pvs25 with a mucosal adjuvant cholera toxin (CT). Immunization induced significant serum IgG with high IgG1/IgG2a ratio (indicative of Th-2 type immune response). Feeding Anopheles dirus mosquitoes with mixtures of immune sera and gametocytemic blood derived from vivax-infected volunteer patients in Thailand significantly reduced both the number of midgut oocysts as well as the percentage of infected mosquitoes. The observed transmission-blocking effect was dependent on immune sera dilution. This study demonstrates for the first time that the mucosally induced mouse immune sera against a human malaria ookinete surface protein can completely block parasite transmission to vector mosquitoes, suggesting the possibility of non-invasive mucosal vaccines against mucosa-unrelated important pathogens like malaria.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adjuvants, Immunologic,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Protozoan,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Protozoan,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Surface,
http://linkedlifedata.com/resource/pubmed/chemical/Cholera Toxin,
http://linkedlifedata.com/resource/pubmed/chemical/Malaria Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Pvs25 protein, P vivax
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0264-410X
|
pubmed:author |
pubmed-author:ArakawaTakeshiT,
pubmed-author:HisaedaHajimeH,
pubmed-author:KishimotoAyanoA,
pubmed-author:MatsumotoYasunobuY,
pubmed-author:RungruangThanapornT,
pubmed-author:SatoYoshiyaY,
pubmed-author:SattabongkotJetsumonJ,
pubmed-author:ShimabukuroIsaoI,
pubmed-author:StowersAnthonyA,
pubmed-author:SuwanabunNantavadeeN,
pubmed-author:ToriiMotomiM,
pubmed-author:TsuboiTakafumiT,
pubmed-author:TsujiNaotoshiN
|
pubmed:issnType |
Print
|
pubmed:day |
4
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3143-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12804841-Adjuvants, Immunologic,
pubmed-meshheading:12804841-Administration, Intranasal,
pubmed-meshheading:12804841-Animals,
pubmed-meshheading:12804841-Anopheles,
pubmed-meshheading:12804841-Antibodies, Protozoan,
pubmed-meshheading:12804841-Antigens, Protozoan,
pubmed-meshheading:12804841-Antigens, Surface,
pubmed-meshheading:12804841-Cholera Toxin,
pubmed-meshheading:12804841-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:12804841-Female,
pubmed-meshheading:12804841-Humans,
pubmed-meshheading:12804841-Immunity, Mucosal,
pubmed-meshheading:12804841-Malaria, Vivax,
pubmed-meshheading:12804841-Malaria Vaccines,
pubmed-meshheading:12804841-Mice,
pubmed-meshheading:12804841-Oocysts,
pubmed-meshheading:12804841-Plasmodium vivax
|
pubmed:year |
2003
|
pubmed:articleTitle |
Serum antibodies induced by intranasal immunization of mice with Plasmodium vivax Pvs25 co-administered with cholera toxin completely block parasite transmission to mosquitoes.
|
pubmed:affiliation |
Division of Molecular Microbiology, Center of Molecular Biosciences, University of the Ryukyus, Nishihara, 903-0213, Okinawa, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|